Answer:
When movement of an object occurs work is measurable.
B) the ability to work top down bottom up
B it the answer Fasho
Answer:
Type I curve
Explanation:
The K-strategist are species characterized by relatively stable populations that fluctuate at the carrying capacity of the habitat or niche in which organisms reside. Elephants are considered as K-strategists because they have a low population growth rate and relatively stable populations. There are three different types of survivorship curves. The Type I curve (also referred to as A curve) is characteristic of k-strategist organisms. Humans and elephants exhibit a Type I survivorship curve in which organisms tend to die when they become elderly. These species have a small number of offspring and provide parental care to ensure their survival. In a Type II survivorship curve, species produce many offspring and only some offspring survive (e.g., birds), while in Type III survivorship curve organisms produce many more offspring and most do not survive (i.e., r-strategists such as frogs or insects).
Diffrent type of biome because we do not live in a rainforest or desert
Answer:
The old idea that coronary heart disease is an infectious disease has gained popularity in recent years, and both viral and bacterial pathogens have been proposed to be associated with the inflammatory changes seen in atherosclerosis. Herpes group viruses, notably cytomegalovirus and herpes simplex type 1, have been associated with atherosclerosis and restenosis. Helicobacter pylori and dental infections have also been linked to atherogenesis, but the evidence seems to favor a respiratory, obligatory intracellular bacterium, Chlamydia pneumoniae. The association was originally found in seroepidemiological studies, but the actual presence of the pathogen in atherosclerotic lesions has been repeatedly demonstrated, and during past year the first successful animal experiments and encouraging preliminary intervention studies were published. The causal relationship has not yet been proven, but ongoing large intervention trials and continuing research on pathogenetic mechanisms may lead to the use of antimicrobial agents in the treatment of coronary heart disease in the future.
Explanation:
© 1998 Lippincott Williams & Wilkins, Inc.
